Flex Pharmaincis A Biotechnology Company Based In Bostonmassachusettsfounded In 2014The Company Specializes In Developing Treatments For Neuromuscular Disordersparticularly Focusing On Muscle Cramps And Spasms Associated With Conditions Like Alsmultiple Sclerosisand Peripheral Neuropathiesco Founded By Nobel Laureate Roderick Mackinnonm D And Bruce Beanph D Flex Pharma Went Public In January 2015 And Has Successfully Raised $40 Million In Fundingthe Company Aims To Create Proprietary Treatments That Inhibit Muscle Cramps By Targeting Neural Mechanismswith A Commitment To Developing Clinically Validated Solutions For Involuntary Muscle Contractionsflex Pharma Holds Six Patents Related To Its Therapeutic Approaches And Is Led By Ceo William Mcvicarph D Who Has Extensive Experience In Clinical Development
